Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now

Stuttgart EUR

Biogen Inc (IDP.SG)

Compare

134.15

-0.35

(-0.26%)

At close: February 28 at 4:24:20 PM GMT+1

No Tool

Measure

UNDO

Redo

All

Favorites

Text

Statistics

Technicals

Fibonacci

Markings

Lines

Annotation

Arrow

Line

Horizontal

Vertical

Rectangle

Trend Line

Measurement Line

Average Line

Callout

Channel

Check

Continuous

Crossline

Elliott Wave

Ellipse

Doodle

Fib Projection

Fib Arc

Fib Fan

Fib Time Zone

Focus

Gann Fan

Gartley

Heart

Pitchfork

Quadrant Lines

Ray

Regression Line

Fib Retracement

Star

Speed Resistance Arc

Speed Resistance Line

Time Cycle

Tirone Levels

Volume Profile

Cross

Loading Chart for IDP.SG

The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease

Biogen Inc. (BIIB): Among the Stocks That Will Go to The Moon According to Analysts

NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects

Biogen Inc. (BIIB): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

Biogen and Stoke Therapeutics to commercialise Dravet syndrome treatment

We Think Biogen's (NASDAQ:BIIB) Healthy Earnings Might Be Conservative

Biogen Strengthens Pipeline With Stoke Therapeutic's Dravet Syndrome Candidate Via Multi-Million Dollar Deal

$Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments$

Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments

Biogen buys rights to Stoke’s rare epilepsy drug

Leqembi And Skyclarys Expected To Drive Biogen's Future Growth: Analysts

Biogen Still Offering Value, RBC Says

PFEB.F Pfizer Inc.

7.75

-1.27%

AZN.L AstraZeneca PLC

11,968.00

-0.42%

PFE Pfizer Inc.

26.43

+1.26%

JNJ Johnson & Johnson

165.02

+0.79%

LLY Eli Lilly and Company

920.63

+1.71%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Biogen Inc (IDP.SG)

Comparisons

Indicators

Technicals

Corporate Events

-0.11%

-3.73%

-11.86%

-26.95%

-7.42%

-34.94%

-51.24%

267.98%

Recent News: IDP.SG